The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, DarioHealth Corp’s stock clocked out at $0.70, up 4.58% from its previous closing price of $0.67. In other words, the price has increased by $4.58 from its previous closing price. On the day, 0.63 million shares were traded. DRIO stock price reached its highest trading level at $0.76 during the session, while it also had its lowest trading level at $0.68.
Ratios:
To gain a deeper understanding of DRIO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.14 and its Current Ratio is at 2.42. In the meantime, Its Debt-to-Equity ratio is 0.42 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, TD Cowen on January 29, 2025, Downgraded its rating to Hold and sets its target price to $1 from $2 previously.
On May 13, 2022, Alliance Global Partners Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $8.75.
On April 22, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $31.Cowen initiated its Outperform rating on April 22, 2021, with a $31 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 12 ’24 when Nelson Steven Charles bought 5,000 shares for $0.91 per share. The transaction valued at 4,546 led to the insider holds 55,000 shares of the business.
Nelson Steven Charles bought 5,000 shares of DRIO for $4,221 on Sep 10 ’24. The Chief Commercial Officer now owns 45,000 shares after completing the transaction at $0.84 per share. On Sep 11 ’24, another insider, Nelson Steven Charles, who serves as the Chief Commercial Officer of the company, bought 5,000 shares for $0.80 each. As a result, the insider paid 4,022 and bolstered with 50,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DRIO now has a Market Capitalization of 29254856 and an Enterprise Value of 29705602. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.08 while its Price-to-Book (P/B) ratio in mrq is 0.38. Its current Enterprise Value per Revenue stands at 1.099 whereas that against EBITDA is -0.599.
Stock Price History:
The Beta on a monthly basis for DRIO is 1.52, which has changed by -0.41818184 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, DRIO has reached a high of $1.93, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 7.29%, while the 200-Day Moving Average is calculated to be -17.42%.
Shares Statistics:
It appears that DRIO traded 433.57K shares on average per day over the past three months and 370080 shares per day over the past ten days. A total of 38.39M shares are outstanding, with a floating share count of 30.92M. Insiders hold about 25.62% of the company’s shares, while institutions hold 18.84% stake in the company. Shares short for DRIO as of 1743379200 were 2704982 with a Short Ratio of 6.24, compared to 1740700800 on 2580920. Therefore, it implies a Short% of Shares Outstanding of 2704982 and a Short% of Float of 7.17.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
